サマリー

ホスホイノシチド3キナーゼ（PI3K）阻害剤の世界市場2022-2026年
Technavioはホスホイノシチド3キナーゼ（PI3K）阻害剤市場を監視しており、2022-2026年の間に71.29百万ドル、予測期間中にCAGR 5.09% で加速して成長すると予測されています。当レポートでは、ホスホイノシチド3キナーゼ（PI3K）阻害剤市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、最近の承認、戦略的提携、特効薬の指定によって牽引されています。
ホスホイノシチド3キナーゼ（PI3K）阻害剤市場の分析には、アプリケーションセグメントと地理的景観が含まれます。
Technavioのホスホイノシチド3-キナーゼ（PI3K）阻害剤市場は、以下のように区分されています。
アプリケーション別
- CLL
- FL
- その他の適応症
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間におけるホスホイノシチド3キナーゼ（PI3K）阻害剤市場の成長を促す主な理由の1つとして、研究適応の拡大を挙げています。また、償還制度や癌に対する意識の高まりは、市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。ホスホイノシチド3キナーゼ（PI3K）阻害剤市場に関する当レポートの対象領域は以下のとおりです。
- ホスホイノシチド3キナーゼ（PI3K）阻害剤の市場サイジング
- ホスホイノシチド3キナーゼ（PI3K）阻害剤の市場予測
- ホスホイノシトイド3キナーゼ（PI3K）阻害剤市場の産業分析
Technavioの強固なベンダー分析は、お客様が市場でのポジションを向上できるように設計されており、これに沿って本レポートでは、Bayer AG、Celon Pharma SA、Curis Inc、Exelixis Inc、Gilead Sciences Inc、Merck KGaA、Molecular Depot LLC、Novartis AG、Secura Bio Inc、TG Therapeutics Incなどのいくつかの主要ホスホイノシチド3-キナーゼ (PI3K) 阻害剤の市場ベンダーに関する詳細分析を提供しています。また、ホスホイノシチド3キナーゼ（PI3K）阻害剤市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/phosphoinositide-3-kinase-pi3k-inhibitors-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 CLL - Market size and forecast 2021-2026
o Exhibit 28: Chart on CLL - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on CLL - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on CLL - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on CLL - Year-over-year growth 2021-2026 (%)
o 5.4 FL - Market size and forecast 2021-2026
o Exhibit 32: Chart on FL - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on FL - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on FL - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on FL - Year-over-year growth 2021-2026 (%)
o 5.5 Other indications - Market size and forecast 2021-2026
o Exhibit 36: Chart on Other indications - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Other indications - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Other indications - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Other indications - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Application
o Exhibit 40: Market opportunity by Application ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Bayer AG
o Exhibit 89: Bayer AG - Overview
o Exhibit 90: Bayer AG - Business segments
o Exhibit 91: Bayer AG - Key offerings
o Exhibit 92: Bayer AG - Segment focus
o 10.4 Celon Pharma SA
o Exhibit 93: Celon Pharma SA - Overview
o Exhibit 94: Celon Pharma SA - Business segments
o Exhibit 95: Celon Pharma SA - Key offerings
o Exhibit 96: Celon Pharma SA - Segment focus
o 10.5 Curis Inc.
o Exhibit 97: Curis Inc. - Overview
o Exhibit 98: Curis Inc. - Product / Service
o Exhibit 99: Curis Inc. - Key offerings
o 10.6 Exelixis Inc.
o Exhibit 100: Exelixis Inc. - Overview
o Exhibit 101: Exelixis Inc. - Product / Service
o Exhibit 102: Exelixis Inc. - Key offerings
o 10.7 Gilead Sciences Inc.
o Exhibit 103: Gilead Sciences Inc. - Overview
o Exhibit 104: Gilead Sciences Inc. - Product / Service
o Exhibit 105: Gilead Sciences Inc. - Key news
o Exhibit 106: Gilead Sciences Inc. - Key offerings
o 10.8 Merck KGaA
o Exhibit 107: Merck KGaA - Overview
o Exhibit 108: Merck KGaA - Business segments
o Exhibit 109: Merck KGaA - Key news
o Exhibit 110: Merck KGaA - Key offerings
o Exhibit 111: Merck KGaA - Segment focus
o 10.9 Molecular Depot LLC.
o Exhibit 112: Molecular Depot LLC. - Overview
o Exhibit 113: Molecular Depot LLC. - Product / Service
o Exhibit 114: Molecular Depot LLC. - Key offerings
o 10.10 Novartis AG
o Exhibit 115: Novartis AG - Overview
o Exhibit 116: Novartis AG - Business segments
o Exhibit 117: Novartis AG - Key offerings
o Exhibit 118: Novartis AG - Segment focus
o 10.11 Secura Bio Inc.
o Exhibit 119: Secura Bio Inc. - Overview
o Exhibit 120: Secura Bio Inc. - Product / Service
o Exhibit 121: Secura Bio Inc. - Key offerings
o 10.12 TG Therapeutics Inc.
o Exhibit 122: TG Therapeutics Inc. - Overview
o Exhibit 123: TG Therapeutics Inc. - Product / Service
o Exhibit 124: TG Therapeutics Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 125: Inclusions checklist
o Exhibit 126: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 127: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 128: Research methodology
o Exhibit 129: Validation techniques employed for market sizing
o Exhibit 130: Information sources
o 11.5 List of abbreviations
o Exhibit 131: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on CLL - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on CLL - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on CLL - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on CLL - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on FL - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on FL - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on FL - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on FL - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Other indications - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Other indications - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Other indications - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Other indications - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Application ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Bayer AG - Overview
Exhibits90: Bayer AG - Business segments
Exhibits91: Bayer AG - Key offerings
Exhibits92: Bayer AG - Segment focus
Exhibits93: Celon Pharma SA - Overview
Exhibits94: Celon Pharma SA - Business segments
Exhibits95: Celon Pharma SA - Key offerings
Exhibits96: Celon Pharma SA - Segment focus
Exhibits97: Curis Inc. - Overview
Exhibits98: Curis Inc. - Product / Service
Exhibits99: Curis Inc. - Key offerings
Exhibits100: Exelixis Inc. - Overview
Exhibits101: Exelixis Inc. - Product / Service
Exhibits102: Exelixis Inc. - Key offerings
Exhibits103: Gilead Sciences Inc. - Overview
Exhibits104: Gilead Sciences Inc. - Product / Service
Exhibits105: Gilead Sciences Inc. - Key news
Exhibits106: Gilead Sciences Inc. - Key offerings
Exhibits107: Merck KGaA - Overview
Exhibits108: Merck KGaA - Business segments
Exhibits109: Merck KGaA - Key news
Exhibits110: Merck KGaA - Key offerings
Exhibits111: Merck KGaA - Segment focus
Exhibits112: Molecular Depot LLC. - Overview
Exhibits113: Molecular Depot LLC. - Product / Service
Exhibits114: Molecular Depot LLC. - Key offerings
Exhibits115: Novartis AG - Overview
Exhibits116: Novartis AG - Business segments
Exhibits117: Novartis AG - Key offerings
Exhibits118: Novartis AG - Segment focus
Exhibits119: Secura Bio Inc. - Overview
Exhibits120: Secura Bio Inc. - Product / Service
Exhibits121: Secura Bio Inc. - Key offerings
Exhibits122: TG Therapeutics Inc. - Overview
Exhibits123: TG Therapeutics Inc. - Product / Service
Exhibits124: TG Therapeutics Inc. - Key offerings
Exhibits125: Inclusions checklist
Exhibits126: Exclusions checklist
Exhibits127: Currency conversion rates for US$
Exhibits128: Research methodology
Exhibits129: Validation techniques employed for market sizing
Exhibits130: Information sources
Exhibits131: List of abbreviations